EcoR1 Capital, LLC (NODELMAN OLEG) purchased $17.2M of ANAB (indirect holdings)
EcoR1 Capital, LLC purchased 374,580 indirectly-held shares of ANAPTYSBIO, INC (ANAB) at an average of $45.98 ($45.66–$46.54, $17.22M total) across 3 trades over 2026-11-16 to 2026-11-18. Filed jointly with NODELMAN OLEG (Director).
How this was made
The 30-second read
Why it matters
ANAB receives a disclosed increase in holdings through open-market purchases totaling $17.2M, but the filing does not include new business developments or forward-looking guidance.
Market read
Traders may treat the disclosure as a mild sentiment input, but it is unlikely to drive a durable repricing without corroborating fundamental catalysts.
What to watch
The transaction is indirect and lacks a stated 10b5-1 plan; without context on prior holdings or intent, the signal strength is uncertain.
Background
The article is an SEC Form 4 insider transaction disclosure for ANAPTYSBIO, INC, reported by EcoR1 Capital, LLC (director, 10% owner) with joint filer NODELMAN OLEG.
Ticker impact
EcoR1 Capital, LLC reported an open-market purchase totaling about $17.2M in ANAB shares via a Form 4 filed 2026-11-18.
Likely limited near-term impact, with any reaction more sentiment-driven than thesis-changing.
This is an SEC Form 4 insider transaction (indirect holdings) with no stated 10b5-1 plan and no accompanying company-specific operational news.
Market effects
Minimal, as the disclosure is company-specific insider buying without sector-wide regulatory or competitive implications.
None indicated.
None indicated.
Counterpoint
Insider-linked buying can be routine portfolio rebalancing or indirect holdings activity, so it may not reflect new positive fundamentals.
Key entities
- issuerANAPTYSBIO, INC
Company whose shares were purchased, disclosed via SEC Form 4.
- insiderEcoR1 Capital, LLC
Reported the open-market purchase totaling about $17.2M in ANAB shares.
- insiderNODELMAN OLEG
Joint filer and director, 10% owner role listed on the Form 4.

